VIEWPOINTS PharmaShots Interview: ViiV Healthcare’s Kimberly Smith Shares Insights on Apretude for the Prevention of HIVBySenior EditorApril 26, 20220Comments
VIEWPOINTS PharmaShots Interview: Janssen’s Soumya D. Chakravarty Shares Insights on Tremfya (guselkumab) for the Treatment of Active Psoriatic ArthritisBySenior EditorApril 25, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in March 2022BySenior EditorApril 21, 20220Comments
VIEWPOINTS PharmaShots Interview: Sanofi’s Chris Soria Shares Insights on Amcenestrant for the Treatment of Breast CancerBySenior EditorApril 20, 20220Comments
VIEWPOINTS PharmaShots Interview: Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy Infants Born at Term or Late PretermBySenior EditorApril 19, 20220Comments
VIEWPOINTS PharmaShots Interview: Reproductive Solutions’ Diana Peninger Shares Insights on ProteX, a Solution for Male InfertilityBySenior EditorApril 18, 20220Comments
INSIGHTS+ Disease of the Month: Chagas Disease (American Trypanosomiasis)BySenior EditorApril 14, 20220Comments
VIEWPOINTS PharmaShots Interview: Fountain Therapeutics’ William Greene Shares Insights on the $15M Series A-2 FinancingBySenior EditorApril 13, 20220Comments
